Novartis Slapped with 15 Day Biz Suspension over Flawed ADR Reporting

February 27, 2015
The Ministry of Health, Labor and Welfare issued on February 27 a 15 day business suspension order to the Japan arm of Swiss pharma titan Novartis AG over the company’s flawed reporting of adverse drug reactions (ADRs). It is the...read more